公司资料
CalciMedica 股价、新闻与催化剂
- 股票代码:
- CALC
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.30 USD (-3.35%)
收盘价
最后更新: 2026年11月5日
12.6M USD
市值
股价为何变动
截至 2026年11月5日，CALC 下跌 3.35%，收于 $1.30。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
CalciMedica is a biotechnology company focused on calcium-channel biology and inflammatory disease. Its story centers on using a targeted mechanism to address severe immune-mediated conditions.
所在地与行业分类
CalciMedica is headquartered in the United States and listed on NASDAQ. It sits in small-cap immunology biotechnology.
商业模式特征
The company depends on clinical validation, translational confidence, and capital discipline while it advances a focused pipeline. Investors watch early data and safety.
生物医药行业定位
CalciMedica occupies a niche inflammation pathway position within biotech. The stock is driven by whether its biology can create a real clinical signal.
未来催化剂
- CalciMedica’s catalysts are calcium-signaling inflammation programs and any clinical update that clarifies whether the company can still build a viable development story. The next step matters because the story remains early.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。